| TERNS PHARMACEUTICALS |
| USA |
| Gesundheit |
| US8808811074 / A2QNWR |
| 430 (Frankfurt) / TERN (NASDAQ) |
| FRA:430, ETR:430, 430:GR, NASDAQ:TERN |
| - |
| https://www.ternspharma.c.. |
|
Terns Pharmaceuticals Inc. is a biopharmaceutical ..
>Volltext.. |
| 627.53 Mio. EUR |
| 359.58 Mio. EUR |
| - |
| -91.16 Mio. EUR |
| -79.65 Mio. EUR |
| -0.91 EUR |
| 0.98 Mio. EUR |
| 126.72 Mio. EUR |
| -64.89 Mio. EUR |
| 24.43 |
| - |
| 13.01% |
| - |
| - |
| - |
| - |
| TERNS PHARMACEUTICALS, TERNS PHARMA, TERNS PHARMACEUTICAL |
| 04.11.25 |
|